Medicines
- Bizengri zenocutuzumab · No generic yet Advanced bile duct cancer with an NRG1 gene fusion
- Imfinzi durvalumab · No generic yet Biliary tract cancer (bile ducts and gallbladder)
- Keytruda pembrolizumab · No generic yet Stomach, esophagus, bile duct and some liver and colorectal cancers
- Keytruda Qlex pembrolizumab and berahyaluronidase alfa-pmph · No generic yet Stomach, esophagus, bile duct and some liver and colorectal cancers
- Lytgobi futibatinib · No generic yet Bile duct cancer in the liver with FGFR2 gene changes
- Pemazyre pemigatinib · No generic yet Bile duct cancer (cholangiocarcinoma) with an FGFR2 change
- Tibsovo ivosidenib · No generic yet Bile duct cancer (cholangiocarcinoma) with an IDH1 mutation
- Ziihera zanidatamab-hrii · No generic yet HER2-positive cancer of the bile ducts or gallbladder